AI Terminal

MODULE: AI_ANALYST

Interactive Q&A, Risk Assessment, Summarization

MODULE: DATA_EXTRACT

Excel Export, XBRL Parsing, Table Digitization

MODULE: PEER_COMP

Sector Benchmarking, Sentiment Analysis

SYSTEM ACCESS LOCKED

Authenticate / Register Log In

Biotage

Report Publication Announcement • Apr 5, 2012

2894_rns_2012-04-05_c9f0deae-35b9-4a57-a4a2-ed6ef6466ff9.pdf

Report Publication Announcement

Open in Viewer

Opens in native device viewer

BiotageAB (publ) publishes its 2011Annual Report and Corporate Governance Report

As from today, Biotage's Annual Report and Corporate Governance Report for 2011 are available at: www.biotage.com

Biotage discloses the information provided herein pursuant to the Swedish Securities Markets Act and/or the Swedish Financial Instruments Trading Act. The information was submitted for publication at 09.00 on April 5 2012.

Contact:

Torben Jörgensen, President and CEO Tel: +46 707 49 05 84, [email protected]

About Biotage

Biotage offers solutions, knowledge and experience in the areas of analytical chemistry and medicinal chemistry. The customers include theworld's largest pharmaceutical and biotech companies, and leading academic institutes. The company is headquartered inUppsala and has offices in theUS, UK, China and Japan. Biotage has 270 employees and had sales of 428.4 MSEKin 2011. Biotage is listed on theNASDAQOMXNordic Stockholmstock exchange. Website: www.biotage.com